期刊文献+

RP-HPLC法测定颗粒型盐酸伊托必利的人血浆浓度

RP-HPLC DETERMINATION OF ITOPRIDE HYDROCHLORIDE IN PLASMA
下载PDF
导出
摘要 目的 :建立一种测定人血浆中盐酸伊托必利血药浓度的反相高效液相色谱法。方法 :采用外标法 ,血样经乙醚—氢氧化钠混合溶剂提取后 ,以nucleosil 2 5 0mm× 4 6mm ,5 μmC18色谱柱为固定相 ,乙腈—磷酸二氢钾为流动相 ,在 2 5 7nm波长处定量检测。结果 :血药浓度在 1 0 0~ 1 6 0 0 0ng·ml- 1范围内线性关系良好 ,最低定量浓度为 1 0 0ng·ml- 1,批内、批间相对标准偏差均小于 7% ,低、中、高三个浓度的相对回收率为 1 0 2 8%~ 1 0 6 3%。检测了 2 0名健康受试者服用盐酸伊托必利后不同时间的血药浓度变化。 结论 :此方法简便、快速、精确 。 Objective:To develop a sensitive and simple reversed phase liquid chromatography method for analysis of itopride hydrochloride in human plasma Methods:Itopride hydrochloride in plasma was extracted with the mixture of ether and sodium hydroxide,then measured by HPLC using a nucleosil C 18 reverse phase column as stationary phase and acetonitrile phosphate buffer as mobile phase Itopride hydrochloride was quantified by ultraviolet absorbance at 257 nm Results:The calibration curve was linear in the range from 10 ng·ml -1 to 1600 ng· ml -1 with a regression coefficient of 0 9995 and the lowest limit of detection of itopride hydrochloride in plasma was 10 ng·ml -1 The relative standard deviation was less than 7% both inter and intra batch,and the recoveries of itopride hydrochloride at three concentration levels of low,medium and high were 102 8%~106 3% The method was used to determine itopride hydrochloride in plasma from twenty volunteers Conclusion:The results of our study demonstrate that this method is rapid and accurate and it can be applied to determination of plasma itopride concentration and to study on pharmacokinetics
出处 《滨州医学院学报》 2004年第5期323-325,共3页 Journal of Binzhou Medical University
关键词 高效液相色谱法 伊托必利 血浆 HPLC itopride plasma
  • 相关文献

参考文献6

  • 1许大波,柯美云.新型促胃肠动力药物伊托必利[J].中国新药杂志,2002,11(6):437-439. 被引量:48
  • 2Iwanaga Y,Miyashita N,Morikawa K,et al. A novel water-soluble dopamine-2 antagonist with anticholinesterase activity in gastrointestinal motor activity. Comparison with domperidone and neostigmine [J].Gastroenterology, 1990,99 ( 2 ): 401
  • 3lwanaga Y,Miyashita N,Mizutani F,et al. stimulatory effect of N-[4-[ 2-( dimethylamino )-ethoxy ] benzyl ]-3, 4-dimethoxybenzamide,hydrochloride( HSR- 803 )on normal and delayed gastrointestinal propulsion [ J ]. Jpn J Pharmacol, 1991,60 ( 3 ): 261
  • 4Iwanaga Y,Suzuki N ,Karo K, et al. Stimulatory effect of HSR - 803 on ileal motor activity [J]. Jpn J Pharmacol, 1993,62 (4) :395
  • 5刘晓梅 邓杨梅.英国和法国分别禁用和限用西沙必利[J].国外医学:药学分册,2001,28(1):64-64.
  • 6Iwanaga Y ,Miyashita N, Mizutani F ,et al. Simultaneous determination of a new gastrointestinal prokinetic agent ( HSR-803 ) and its metabolites in human scrum and urine by high-performance liquid chromatography using automated column-switching[ J ]. J Chromatogr, 1992,576(1):174

二级参考文献17

  • 1[1]Dominguez-Munoz JE.Targeting the abnormalities of gastroduodenal functions in functional dyspepsia[J].Dig Dis,2001,19(3)∶195-200.
  • 2[2]Iwanaga Y,Miyashita N,Saito T,et al.Gastroprokinetic effect of a new benzamide derivative itopride and its action mechanisms in conscious dogs[J].Jpn J Pharmacol,1996,71(2)∶129-137.
  • 3[3]Iwanaga Y,Kimura T,Miyashita N,et al.Characterization of acetylcholinesterase-inhibition by itopride[J].Jpn J Pharmacol,1994,66(3)∶317-322.
  • 4[4]Harasawa S,Miwa T.Effect of itopride hydrochloride on gastric emptying in chronic gastritis patients[J].Jpn Pharmacol Ther,1993,11(21)∶4189-4195.
  • 5[5]Nakajima M,Uematsu T,Nakajima S.Phase I study of HSR-803[J].Jpn Pharmacol Ther,1993,11(21)∶4157-4173.
  • 6[6]Mushiroda T,Douya R,Takahara E,et al.The involvement of flavin-containing monooxygenase but not CYP3A4 in metabolism of itopride hydrochloride,a gastroprokinetic agent:comparison with cisapride and mosapride citrate[J].Drug Metab Dispos,2000,28(10)∶1231-1237.
  • 7[7]Miyoshi A,Omata S,Miwa T,et al.Clinical effect of HSR-803 on digestive symptoms:early phase Ⅱ study[J].Jpn Pharmacol Ther,1993,11(21)∶4175-4187.
  • 8[8]Miyoshi A,Masamune O,Sekiguchi T,et al.Clinical evaluation of itopride hydrochloride for gastrointestinal symptoms associated with chronic gastritis:multi-center double-blind clinical trial using cisapride as control drug[J].Jpn Pharmacol Ther,1994,12(4)∶261-279.
  • 9[9]Miyoshi A,Masamune O,Sekiguchi T,et al.Dose finding study of a gastroprokinetic agent,HSR-803,on gastrointestinal complations: late phase II study[J].Jpn Pharmacol Ther,1993,11(3)∶2107-2128.
  • 10[10]Hirakawa T,Yoshizawa M,Kagawa T,et al.Clinical effect of the peristalsis enhancer itopride hydrochloride on the digestive symptoms of chronic gastritis[J].Clinical Report,1993,15(27)∶5901-5906.

共引文献53

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部